Mount Sinai DoctorsTreats Adults
Accepting New Patients
Caitlin Carr, MD
Gynecologic Oncology
About Me
Caitlin Carr, MD, is a board certified obstetrician-gynecologist specializing in gynecologic oncology and an Assistant Professor in the Raquel and Jaime Gilinski Depart of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai. Dr. Carr’s areas of special interest include advanced abdominal-pelvic and minimally invasive surgical procedures, management of patients with hereditary cancer syndromes, and clinical trials for advancement of novel chemotherapeutics.
Dr. Carr first joined Mount Sinai as a fellow in the Division of Gynecologic Oncology. She received her medical degree from the University of Tennessee College of Medicine and went on to complete her residency in obstetrics and gynecology at the Cleveland Clinic Foundation, where she was recognized with the Resident Teacher of the Year Award. As a third-year resident, she was selected for the Felix Rutledge Fellowship resident rotation in gynecologic oncology at the University of Texas MD Anderson Cancer Center.
Dr. Carr has been published in numerous peer-reviewed journals on topics such as clinicopathologic characteristics and outcomes of endometrial cancer patients with mismatch repair deficiency, the role of chemotherapy for early stage endometrial cancer with lymphovascular space invasion, long-term outcomes for single-port risk-reducing salpingo-oophorectomy for women at risk of gynecologic cancer, inflammatory markers in gynecologic oncology patients hospitalized with COVID-19, and racial disparities in patients with COVID-19 infection and gynecologic malignancy. Dr. Carr has presented on her research related to the association of the COVID -19 pandemic and mental health outcomes of gynecologic oncology providers at multiple national meetings, which has earned her national media attention.
Dr. Carr is a member of the American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncology, where she serves as a member of the Wellness Committee and Communications Committee.
Areas of Cancer Focus include: Ovarian Cancer, Fallopian Tube Carcinoma, Uterine Cancer, Cervical Cancer, Germ Cell Tumors, Vaginal Cancer
Areas of Surgical Focus include: Hysterectomy, Minimally Invasive Hysterectomy, Laparoscopy, Oophorectomy, Exploratory Laparotomy, Lymph Node Biopsy, Ovarian Cyst Removal, Cystectomy, Lysis Of Adhesions, Dilation And Curettage, Cystoscopy
Areas of Clinical Focus include: Gynecologic Malignancies, Minimally Invasive Gynecologic Surgery, Pelvic Mass, Ovarian Cyst, Genetic Screening, BRCA, Clinical Trials, Chemotherapy, Ascites, Cervical Dysplasia, Cervical Conization, Loop Electrosurgical Excision Procedure, Colposcopy
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Caitlin Carr, MD, is a board certified obstetrician-gynecologist specializing in gynecologic oncology and an Assistant Professor in the Raquel and Jaime Gilinski Depart of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai. Dr. Carr’s areas of special interest include advanced abdominal-pelvic and minimally invasive surgical procedures, management of patients with hereditary cancer syndromes, and clinical trials for advancement of novel chemotherapeutics.
Dr. Carr first joined Mount Sinai as a fellow in the Division of Gynecologic Oncology. She received her medical degree from the University of Tennessee College of Medicine and went on to complete her residency in obstetrics and gynecology at the Cleveland Clinic Foundation, where she was recognized with the Resident Teacher of the Year Award. As a third-year resident, she was selected for the Felix Rutledge Fellowship resident rotation in gynecologic oncology at the University of Texas MD Anderson Cancer Center.
Dr. Carr has been published in numerous peer-reviewed journals on topics such as clinicopathologic characteristics and outcomes of endometrial cancer patients with mismatch repair deficiency, the role of chemotherapy for early stage endometrial cancer with lymphovascular space invasion, long-term outcomes for single-port risk-reducing salpingo-oophorectomy for women at risk of gynecologic cancer, inflammatory markers in gynecologic oncology patients hospitalized with COVID-19, and racial disparities in patients with COVID-19 infection and gynecologic malignancy. Dr. Carr has presented on her research related to the association of the COVID -19 pandemic and mental health outcomes of gynecologic oncology providers at multiple national meetings, which has earned her national media attention.
Dr. Carr is a member of the American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncology, where she serves as a member of the Wellness Committee and Communications Committee.
Areas of Cancer Focus include: Ovarian Cancer, Fallopian Tube Carcinoma, Uterine Cancer, Cervical Cancer, Germ Cell Tumors, Vaginal Cancer
Areas of Surgical Focus include: Hysterectomy, Minimally Invasive Hysterectomy, Laparoscopy, Oophorectomy, Exploratory Laparotomy, Lymph Node Biopsy, Ovarian Cyst Removal, Cystectomy, Lysis Of Adhesions, Dilation And Curettage, Cystoscopy
Areas of Clinical Focus include: Gynecologic Malignancies, Minimally Invasive Gynecologic Surgery, Pelvic Mass, Ovarian Cyst, Genetic Screening, BRCA, Clinical Trials, Chemotherapy, Ascites, Cervical Dysplasia, Cervical Conization, Loop Electrosurgical Excision Procedure, Colposcopy
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Abnormal Uterine Bleeding
- Adenomyosis
- Ascites
- Biopsy
- Cervical Cancer
- Cervical Conization
- Cervical Dysplasia
- Colposcopy
- Cystoscopy
Show More
Education
MD, University of Tennessee Health Science Center
Residency, Obstetrics & Gynecology
Cleveland Clinic Foundation
Fellowship, Gynecologic Oncology
Mount Sinai Hospital
Certifications
American Board of Obstetrics and Gynecology
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Blavatnik Family Chelsea Medical Center325 W 15th Street, New York, NY, 10011
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Carr has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Carr has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.